Development of an online solid-phase extraction-liquid chromatography-mass spectrometric analysis of oxcarbazepine and its active metabolite licarbazepine from plasma with a direct injection step

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Sep 1:1125:121710. doi: 10.1016/j.jchromb.2019.06.037. Epub 2019 Jul 2.

Abstract

We developed an online solid phase extraction procedure using a hydrophilic-lipophilic balance sorbent, with reversed-phase liquid chromatography-high-resolution mass spectroscopy for the determination of oxcarbazepine and its active metabolite licarbazepine in plasma samples. The analytes were detected using a high-resolution Q Orbitrap mass spectrometer with targeted-selected ion monitoring (t-SIM) in positive scan mode. Under the optimized conditions, the method was linear with R2 values >0.99. The method was linear from 0.008 to 2.000 μg mL-1 and the lower limit of quantification was 0.008 μg mL-1 for both oxcarbazepine and licarbazepine. Recoveries ranged from 92.34 to 104.27% and from matrix-matched samples from 94.26 to 104.19%. The intraday and interday precision RSD values were <9.13% with an associated accuracy of 92.71 to 104.06%. The total time for the one step online procedure was only 8 min. This method provides a direct and accurate measurement for therapeutic drug monitoring of oxcarbazepine and its active metabolite licarbazepine.

Keywords: Licarbazepine; Online-SPE-LC-HRMS; Oxcarbazepine; Therapeutic drug monitoring.

Publication types

  • Evaluation Study

MeSH terms

  • Chromatography, High Pressure Liquid / methods*
  • Dibenzazepines / blood
  • Dibenzazepines / isolation & purification*
  • Humans
  • Oxcarbazepine / blood
  • Oxcarbazepine / isolation & purification*
  • Solid Phase Extraction / methods*
  • Tandem Mass Spectrometry / methods*

Substances

  • Dibenzazepines
  • Oxcarbazepine
  • 10,11-dihydro-10-hydroxy-5H-dibenz(b,f)azepine-5-carboxamide